loading
Schlusskurs vom Vortag:
$3.13
Offen:
$3.1035
24-Stunden-Volumen:
3,319
Relative Volume:
0.11
Marktkapitalisierung:
$5.70M
Einnahmen:
$770.00K
Nettoeinkommen (Verlust:
$-38.84M
KGV:
-0.2263
EPS:
-14.2049
Netto-Cashflow:
$-43.02M
1W Leistung:
-16.49%
1M Leistung:
-52.65%
6M Leistung:
-31.60%
1J Leistung:
-64.65%
1-Tages-Spanne:
Value
$3.1035
$3.21
1-Wochen-Bereich:
Value
$3.1035
$3.9899
52-Wochen-Spanne:
Value
$3.1035
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Firmenname
Lyra Therapeutics Inc
Name
Telefon
617-373-4600
Name
Adresse
480 ARSENAL WAY, WATERTOWN, MA
Name
Mitarbeiter
87
Name
Twitter
@LyraTx
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
LYRA's Discussions on Twitter

Vergleichen Sie LYRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LYRA
Lyra Therapeutics Inc
3.2099 5.56M 770.00K -38.84M -43.02M -14.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.56 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
743.96 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
444.05 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
922.30 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
197.34 42.58B 447.02M -1.18B -906.14M -6.1812

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-07 Herabstufung BofA Securities Buy → Underperform
2024-05-07 Herabstufung H.C. Wainwright Buy → Neutral
2024-05-07 Herabstufung Jefferies Buy → Hold
2024-05-06 Herabstufung William Blair Outperform → Mkt Perform
2023-10-06 Fortgesetzt BTIG Research Buy
2023-08-31 Eingeleitet H.C. Wainwright Buy
2022-05-24 Eingeleitet Cantor Fitzgerald Overweight
2020-05-26 Eingeleitet BTIG Research Buy
2020-05-26 Eingeleitet BofA/Merrill Buy
2020-05-26 Eingeleitet Jefferies Buy
2020-05-26 Eingeleitet William Blair Outperform
Alle ansehen

Lyra Therapeutics Inc Aktie (LYRA) Neueste Nachrichten

pulisher
07:22 AM

Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com

07:22 AM
pulisher
Nov 20, 2025

Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de

Nov 15, 2025
pulisher
Nov 14, 2025

PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus

Nov 14, 2025
pulisher
Nov 14, 2025

What indicators show strength in Lyra Therapeutics Inc.2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Major Shareholder Sells Thousands of Lyra Therapeutics Shares! - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results - Investing.com Canada

Nov 13, 2025
pulisher
Nov 12, 2025

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com

Nov 12, 2025
pulisher
Nov 12, 2025

Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks - TipRanks

Nov 12, 2025

Finanzdaten der Lyra Therapeutics Inc-Aktie (LYRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Lyra Therapeutics Inc-Aktie (LYRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 12 '25
Sale
4.06
8,745
35,499
17,239
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 11 '25
Sale
4.31
5,320
22,954
18,122
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 06 '25
Sale
5.18
32,149
166,529
22,521
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 07 '25
Sale
4.75
19,739
93,695
20,528
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 10 '25
Sale
4.54
18,502
83,995
18,659
$38.50
price up icon 0.09%
$30.28
price up icon 0.65%
$101.88
price up icon 0.27%
$97.38
price up icon 0.71%
biotechnology ONC
$345.48
price down icon 1.51%
$198.39
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):